in september 2008, the group announced that its wholly-owned subsidiary, shenzhen liancheng medicine company limited, entered into an agreement which disposed of its 70% interest in cangnan county hongtai medicine co., ltd.
the disposal is in line with the group’s strategy of focusing on the development of high-margin exclusive and private label products.